A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma

Authors

Keywords

Journal

Volume 65, Issue 3, Pages 509-514

Publisher

Springer Nature

Online

2009-07-11

DOI

10.1007/s00280-009-1057-y

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now